Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers. Coulter JB, Easwaran H. PLoS Biol 2023;21:e3002081.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Coulter JB, Easwaran H. Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers. PLoS Biol 2023;21:e3002081.
PMID: 37104249